MCID: HRM006
MIFTS: 44

Hermansky-Pudlak Syndrome 3 malady

Categories: Genetic diseases, Rare diseases, Eye diseases, Skin diseases, Metabolic diseases, Blood diseases

Aliases & Classifications for Hermansky-Pudlak Syndrome 3

About this section

Aliases & Descriptions for Hermansky-Pudlak Syndrome 3:

Name: Hermansky-Pudlak Syndrome 3 50 11 23 13 68 25 12 66
Hps3 23 68
Albinism with Hemorrhagic Diathesis and Pigmented Reticuloendothelial 68
 
Delta Storage Pool Disease 68
Hps 3 23
Hps-3 23

Characteristics:

HPO:

62
hermansky-pudlak syndrome 3:
Inheritance: autosomal recessive inheritance


Classifications:



External Ids:

OMIM50 614072
Disease Ontology11 DOID:0060541
MedGen35 CN068829
MeSH37 D022861

Summaries for Hermansky-Pudlak Syndrome 3

About this section
UniProtKB/Swiss-Prot:68 Hermansky-Pudlak syndrome 3: A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

MalaCards based summary: Hermansky-Pudlak Syndrome 3, also known as hps3, is related to isolated delta-storage pool disease and hermansky-pudlak syndrome 1, and has symptoms including visual impairment, nystagmus and abnormal bleeding. An important gene associated with Hermansky-Pudlak Syndrome 3 is HPS3 (HPS3, Biogenesis Of Lysosomal Organelles Complex 2 Subunit 1), and among its related pathways are Tyrosine metabolism and A-beta Pathways: Uptake and Degradation. Affiliated tissues include lung, and related mouse phenotypes are hearing/vestibular/ear and no phenotypic analysis.

Disease Ontology:11 A type of hermasky-pudlak syndrome caused by homozygous or compound heterozygous mutation in the hps3 gene on chromosome 3q24.

Description from OMIM:50 614072

Related Diseases for Hermansky-Pudlak Syndrome 3

About this section

Diseases in the Hermansky-Pudlak Syndrome family:

hermansky-pudlak syndrome 3 Hermansky-Pudlak Syndrome 2
Hermansky-Pudlak Syndrome 7 Hermansky-Pudlak Syndrome 1
Hermansky-Pudlak Syndrome 6 Hermansky-Pudlak Syndrome 5
Hermansky-Pudlak Syndrome 9 Hermansky-Pudlak Syndrome 8
Hermansky-Pudlak Syndrome 4

Diseases related to Hermansky-Pudlak Syndrome 3 via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 43)
idRelated DiseaseScoreTop Affiliating Genes
1isolated delta-storage pool disease12.3
2hermansky-pudlak syndrome 111.6
3hermansky-pudlak syndrome 211.3
4hepatitis c virus10.6
5cervical cancer, somatic10.6
6ectodermal dysplasia 5, hair/nail type10.5HPS5, HPS6
7megakaryocytic tumor10.5HPS3, HPS6
8fibroepithelial polyp of the anus10.4MITF, PMEL
9gnathodiaphyseal dysplasia10.4HPS5, HPS6
10waardenburg syndrome/ocular albinism, digenic10.4MITF, TYR
11pyloric stenosis, infantile hypertrophic, 310.3MITF, TYR
12acute pandysautonomia10.3HPS3, HPS5, HPS6
13spasticity multiple exostoses10.3PMEL, TYR
14albinism, oculocutaneous, type ib10.3MITF, TYR
15melanoma, cutaneous malignant 810.3MITF, TYR
16junctional epidermolysis bullosa10.3PMEL, TYR
17childhood brain stem glioma10.3PMEL, TYR
18anal margin carcinoma10.3MITF, TYR
19acute apical periodontitis10.3PMEL, TYR
20stomach diverticulosis10.3MITF, TYR
21renal oncocytoma10.3HPS3, HPS5, HPS6
22spindle cell hemangioma10.2PMEL, TYR
23hermansky-pudlak syndrome10.1
24chediak-higashi syndrome10.1TYR, TYRP1
25epithelioid type angiomyolipoma10.1MITF, TYR
26conjunctival pigmentation10.1PMEL, TYR, TYRP1
27arterial calcification of infancy10.0MITF, TYR, TYRP1
28dyschromatosis symmetrica hereditaria10.0MITF, TYR, TYRP1
29pustulosis of palm and sole10.0MITF, PTPRC
30leukemoid reaction10.0MITF, PMEL, TYR
31homocystinuria10.0MITF, TYR, TYRP1
32learning disability10.0MITF, PMEL, TYR
33heavy chain disease10.0MITF, TYR
34penis carcinoma in situ10.0MITF, TYR
35brown-vialetto-van laere syndrome10.0MITF, PMEL, TYR
36birth defects10.0TYR, TYRP1
37ciliary body spindle cell melanoma9.9MITF, PMEL, TYR
38partial optic atrophy9.9MITF, TYR, TYRP1
39primary cutaneous amyloidosis9.9HPS3, HPS6, TYR, TYRP1
40hermaphroditism9.6HPS3, HPS5, HPS6, TYR, TYRP1
41vertebrobasilar insufficiency9.2APOE, SELP
42nail disorder, nonsyndromic congenital, 79.2DCT, MITF, PMEL, TYR, TYRP1
43autism susceptibility 166.4APOE, DCT, HPS3, HPS5, HPS6, MITF

Graphical network of the top 20 diseases related to Hermansky-Pudlak Syndrome 3:



Diseases related to hermansky-pudlak syndrome 3

Symptoms for Hermansky-Pudlak Syndrome 3

About this section


Clinical features from OMIM:

614072

HPO human phenotypes related to Hermansky-Pudlak Syndrome 3:

id Description Frequency HPO Source Accession
1 visual impairment HP:0000505
2 nystagmus HP:0000639
3 abnormal bleeding HP:0001892
4 abnormal platelet granules HP:0011883

Drugs & Therapeutics for Hermansky-Pudlak Syndrome 3

About this section

Drugs for Hermansky-Pudlak Syndrome 3 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 7)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PirfenidonePhase 24653179-13-840632
Synonyms:
5-21-07-00197 (Beilstein Handbook Reference)
5-Methyl-1-phenyl-1H-pyridin-2-one
5-Methyl-1-phenyl-2(1H)-pyridone
5-Methyl-1-phenyl-2-(1H)-pyridone
5-methyl-1-phenylpyridin-2(1H)-one
5-methyl-1-phenylpyridin-2-one
53179-13-8
AC-6797
AC1L2454
AMR 69
AMR-69
BRD-K96862998-001-03-1
BRN 1526549
Bio1_000397
Bio1_000886
Bio1_001375
C093844
C12H11NO
CID40632
D01583
Deskar
EN000704
EU-0100907
Esbriet
F-647
FT-0082541
 
I01-1466
KS-5041
LS-133834
Lopac-P-2116
Lopac0_000907
MLS000860042
NCGC00015806-01
NCGC00015806-03
NCGC00015806-05
NCGC00024992-01
NCGC00024992-02
NCGC00024992-03
P 2116
P2116_SIGMA
PIRFENIDONE
Pirespa
Pirfenidona
Pirfenidona [INN-Spanish]
Pirfenidone (Deskar)
Pirfenidone (JAN/USAN/INN)
Pirfenidone [USAN:INN]
Pirfenidonum
Pirfenidonum [INN-Latin]
S-7701
SMR000326900
Tocris-1093
ZINC00001958
2
PravastatinPhase 1, Phase 214781093-37-054687
Synonyms:
(+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid
(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid
(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid
3beta-Hydroxycompactin
81093-37-0
81131-70-6 (hydrochloride salt)
AC1L1HJL
AC1Q5T3M
BIDD:GT0773
BRD-K60511616-236-01-4
C01844
C23H36O7
CCRIS 7557
CHEMBL1144
CID54687
Compactin
D08410
DB00175
Elisor
Eptastatin
FT-0082682
KS-5015
LS-94713
Lipostat
Mevalothin
Mevalotin
Mevastatin
Mevinolin
 
Oliprevin
Pravachol
Pravaselect
Pravastatin (INN)
Pravastatin Sodium
Pravastatin Sodium Salt
Pravastatin [INN:BAN]
Pravastatin acid
Pravastatin sodium
Pravastatin tert-Octylamine Salt
Pravastatina
Pravastatina [Spanish]
Pravastatine
Pravastatine [French]
Pravastatinum
Pravastatinum [Latin]
Pravator
Pravator (TN)
RMS-431
SQ-31,000
Selectin
Selektine
Selipran
UNII-KXO2KT9N0G
Vasten
nchembio.301-comp7
nchembio790-comp15
pravastatin
pravastatina
pravastatine
pravastatinum
3
ZileutonPhase 1, Phase 220111406-87-260490
Synonyms:
(+-)-1-(1-Benzo(b)thien-2-ylethyl)-1-hydroxyurea
(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea
(+/-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea
1-[1-(1-benzothien-2-yl)ethyl]-1-hydroxyurea
1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea
111406-87-2
133305-01-8
154003-29-9
A 64077
A-64077
ABBOTT-64077
ABT-077
AC-13198
AC1L1TCB
AKOS000280127
Abbot 64077
Abbott 64077
Abbott brand of zileuton
Bio-0924
C063449
C11H12N2O2S
CHEBI:10112
CHEMBL93
CID60490
CPD000466377
CTI-02
D00414
DB00744
FT-0082368
 
HMS2051M20
HMS2089J12
HMS2093H06
LS-158908
Leutrol
MLS000759510
MLS001424079
MolPort-000-883-253
MolPort-003-850-877
N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea
N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea
N-[1-(benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea
NCGC00159453-02
Prestwick0_001090
S1443_Selleck
SAM001246738
SMR000466377
UNII-V1L22WVE2S
ZILEUTON
ZYFLO, Zileuton
Zileuton
Zileuton (USP/INN)
Zileuton [USAN:INN:BAN]
Zileutonum
Zileutonum [INN-Latin]
Ziluton
Zyflo
Zyflo (TN)
Zyflo CR
Zyflo Filmtab
4
LosartanPhase 1, Phase 2281114798-26-43961
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
114798-26-4
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
AC1L1H3Q
BIDD:GT0286
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H23ClN6O
CHEBI:6541
CHEMBL191
CID3961
CL23623
Cozaar
D08146
DB00678
DUP 89
DuP 89
DuP-753
HMS1922J13
HMS2093E22
Hyzaar
I14-9710
Jsp001094
KBio2_002193
 
KBio2_004761
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
L000351
LOSARTAN POTASSIUM
LS-78746
Lacidipine
Lortaan
Losartan
Losartan (INN)
Losartan Potassium
Losartan [INN:BAN]
Losartan monopotassium salt
Losartic
Losartic (TN)
MK-954
MK954
MolPort-003-666-553
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
Oprea1_644635
SPBio_001893
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
Spectrum_001713
UNII-JMS50MPO89
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
losartan
losartan potassium
5
ErythromycinPhase 1, Phase 292114-07-812560
Synonyms:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
,10-dione
114-07-8
3''-O-demethylerythromycin
374700-25-1
45673_FLUKA
45674_FLUKA
79235-06-6
82343-12-2
A/T/S
AC-12744
AC1L1FIQ
AC1L1QK7
AC1L1ZUR
AC1O8PVA
AC1Q2UA1
AC1Q6O1S
AI3-50138
AR-1A4414
AR-1H0723
Abboticin
Abomacetin
Acneryne
Acnesol
Ak-Mycin
Ak-mycin
Akne Cordes Losung
Akne-Mycin
Akne-mycin (TN)
Aknederm Ery Gel
Aknemycin
Aknin
AustriaS
BB_NC-1332
BIDD:GT0017
BPBio1_000312
BSPBio_000282
BSPBio_002480
Benzamycin
Benzamycin Pak
Bristamycin
C-Solve-2
C01912
C37H67NO13
CCRIS 9078
CHEBI:42355
CHEMBL532
CID12560
CID3255
CID6713919
CID8233
D00140
DB00199
Del-Mycin
Derimer
Deripil
DivK1c_000294
DivK1c_000397
DivK1c_000702
Dotycin
Dumotrycin
E- mycin, Erycin, Robimysin
E-Base
E-Base (base)
E-Glades
E-Mycin
E-Mycin (base)
E-Solve 2
E0751
E0774_SIAL
E5389_SIGMA
E6376_SIAL
E7904_SIGMA
EINECS 204-040-1
EM
EMU
ERY
ERYC
ERYC (base)
ERYTHROMYCIN STEARATE
ETS
Emgel
Emu-V
Emu-Ve
Emuvin
Emycin
Endoeritrin
Erecin
Erimycin-T
Erisone
Eritomicina
Eritrocina
Eritromicina
Eritromicina [INN-Spanish]
Ermycin
Eros
Ery-B
Ery-Diolan
Ery-Sol
Ery-Tab
Ery-Tab (base)
Ery-maxin
Eryacne
Eryacnen
Eryc
Eryc (TN)
Eryc 125
Eryc Sprinkles
Eryc-125
Eryc-250
Erycen
Erycette
Erycin
Erycinum
Eryderm
Erydermer
Erygel
Erygel (TN)
Eryhexal
Erymax
Erymed
Erypar
Erysafe
Erytab
Erythra-Derm
Erythro
Erythro-Statin
Erythro-Teva
Erythrocin
Erythrocin Stearate
Erythroderm
Erythrogran
Erythroguent
Erythromast 36
Erythromid
Erythromycin
Erythromycin & VRC3375
Erythromycin (JP15/USP/INN)
 
Erythromycin A
Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279
Erythromycin B
Erythromycin C
Erythromycin Lactate
Erythromycin Ointment
Erythromycin Stearate
Erythromycin [INN:BAN:JAN]
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin intravenous
Erythromycin lactobionate
Erythromycin oxime
Erythromycin sodium lauryl sulfate
Erythromycin, compd. with monododecyl sulfate, sodium salt
Erythromycine
Erythromycine [INN-French]
Erythromycinum
Erythromycinum [INN-Latin]
Erytop
Erytrociclin
Ethril 250
HMS1568O04
HMS1920M04
HMS2091D05
HMS500O16
HSDB 3074
I06-0245
IDI1_000294
IDI1_000397
IDI1_000702
Ilocaps
Ilosone
Ilosone (estolate)
Iloticina
Ilotycin
Ilotycin Gluceptate
Ilotycin T.S
Ilotycin T.S.
Inderm
Inderm Gel
IndermRetcin
KBio1_000294
KBio1_000397
KBio1_000702
KBio2_000555
KBio2_001139
KBio2_003123
KBio2_003707
KBio2_005691
KBio2_006275
KBioGR_001175
KBioSS_000555
KBioSS_001139
KST-1A8261
Kesso-Mycin
LMPK04000006
LS-187077
LS-64648
Latotryd
Lederpax
MLS001066618
Mephamycin
Mercina
MolPort-000-772-161
MolPort-002-507-378
MolPort-003-933-429
N-Methylerythromycin A
NCGC00179619-01
NCI-C55674
NINDS_000294
NINDS_000397
NINDS_000702
NSC 55929
NSC55929
Oftalmolosa Cusi Eritromicina
Oftamolets
PCE Dispertab (base)
Paediathrocin
Pantoderm
Pantodrin
Pantomicina
Pce
Pce (TN)
Pfizer-e
Pharyngocin
Prestwick0_000151
Prestwick1_000151
Prestwick2_000151
Prestwick3_000151
Prestwick_205
Primacine
Propiocine
Proterytrin
R-P Mycin
Retcin
Robimycin
Romycin
SBB057401
SMP1_000119
SMR000544946
SPBio_000778
SPBio_001226
SPBio_002221
SPECTRUM1500280
STK249736
Sans-acne
Sansac
Serp-AFD
Skid Gel E
Spectrum2_000759
Spectrum2_001263
Spectrum4_000538
Spectrum5_001596
Spectrum_000115
Spectrum_000659
Staticin
Staticin (TN)
Stiemicyn
Stiemycin
Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin
T-Stat
T-stat (TN)
Taimoxin-F
Theramycin Z
Tiloryth
Tiprocin
Torlamicina
UNII-63937KV33D
Udima Ery Gel
Wemid
Wyamycin S
adecane-2,10-dione (non-preferred name)
bmse000664
erythro
erythromycin
nchembio.285-comp13
6
AcetylcysteinePhase 1, Phase 2304616-91-112035
Synonyms:
(2R)-2-acetylamino-3-Sulfanylpropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoic acid
(R)-Mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
 
Fluprowit
L-Acetylcysteine
L-alpha-acetamido-beta-Mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-ACETYL-L-cysteine
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
7
angiotensin IIPhase 1, Phase 2113568521-88-0, 11128-99-7172198, 65143
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II

Interventional clinical trials:

idNameStatusNCT IDPhase
1Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak SyndromeActive, not recruitingNCT00001596Phase 2
2Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak SyndromeTerminatedNCT00467831Phase 1, Phase 2
3Medical Treatment of Colitis in Patients With Hermansky-Pudlak SyndromeWithdrawnNCT00514982Phase 2
4Study of Megakaryocytes From Patients With Abnormal Platelet VesiclesCompletedNCT00086476

Search NIH Clinical Center for Hermansky-Pudlak Syndrome 3

Genetic Tests for Hermansky-Pudlak Syndrome 3

About this section

Genetic tests related to Hermansky-Pudlak Syndrome 3:

id Genetic test Affiliating Genes
1 Hermansky-Pudlak Syndrome 325 23 HPS3

Anatomical Context for Hermansky-Pudlak Syndrome 3

About this section

MalaCards organs/tissues related to Hermansky-Pudlak Syndrome 3:

34
Lung

Animal Models for Hermansky-Pudlak Syndrome 3 or affiliated genes

About this section

MGI Mouse Phenotypes related to Hermansky-Pudlak Syndrome 3:

39 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053778.8APOE, HPS5, HPS6, MITF, TYRP1
2MP:00030127.5APOE, HPS3, HPS5, MITF, PMEL, PTPRC
3MP:00053677.4APOE, HPS5, HPS6, PTPRC, SELP, TYR
4MP:00053907.3APOE, MITF, PTPRC, SELP, TYR, TYRP1
5MP:00053877.1APOE, HPS3, HPS5, HPS6, MITF, PTPRC
6MP:00011867.1APOE, DCT, HPS3, HPS5, HPS6, MITF
7MP:00053977.1APOE, HPS3, HPS5, HPS6, MITF, PMEL
8MP:00107716.6APOE, DCT, HPS3, HPS5, HPS6, MITF
9MP:00053786.6APOE, HPS5, HPS6, MITF, PTPRC, SELP
10MP:00036316.6APOE, DCT, HPS6, MITF, PTPRC, SELP
11MP:00053916.2APOE, DCT, HPS3, HPS5, HPS6, MITF
12MP:00053765.7APOE, HPS3, HPS5, HPS6, MITF, PMEL

Publications for Hermansky-Pudlak Syndrome 3

About this section

Articles related to Hermansky-Pudlak Syndrome 3:

idTitleAuthorsYear
1
The Hermansky-Pudlak syndrome 3 (cocoa) protein is a component of the biogenesis of lysosome-related organelles complex-2 (BLOC-2). (14718540)
2004

Variations for Hermansky-Pudlak Syndrome 3

About this section

UniProtKB/Swiss-Prot genetic disease variations for Hermansky-Pudlak Syndrome 3:

68
id Symbol AA change Variation ID SNP ID
1HPS3p.Arg397TrpVAR_013251rs121908316

Clinvar genetic disease variations for Hermansky-Pudlak Syndrome 3:

5
id Gene Variation Type Significance SNP ID Assembly Location
1NM_032383.4(HPS3): c.2888-1612G> Asingle nucleotide variantPathogenicrs281865096GRCh37Chr 3, 148888270: 148888270
2HPS3NM_032383.4(HPS3): c.(-3010)_(217)+692deldeletionPathogenicGRCh38Chr 3, 149126714: 149130632
3HPS3NM_032383.4(HPS3): c.1163+1G> Asingle nucleotide variantPathogenicrs201227603GRCh37Chr 3, 148863334: 148863334
4HPS3NM_032383.4(HPS3): c.1691+2T> Gsingle nucleotide variantPathogenicrs281865093GRCh37Chr 3, 148875320: 148875320
5NM_032383.4(HPS3): c.2482-2A> Gsingle nucleotide variantPathogenicrs397507168GRCh38Chr 3, 149163840: 149163840
6NM_032383.4(HPS3): c.2589+1G> Csingle nucleotide variantPathogenicrs281865095GRCh37Chr 3, 148881737: 148881737
7HPS3NM_032383.4(HPS3): c.1189C> T (p.Arg397Trp)single nucleotide variantPathogenicrs121908316GRCh37Chr 3, 148868411: 148868411
8HPS3HPS3, 89-BP INSinsertionPathogenic

Expression for genes affiliated with Hermansky-Pudlak Syndrome 3

About this section
Search GEO for disease gene expression data for Hermansky-Pudlak Syndrome 3.

Pathways for genes affiliated with Hermansky-Pudlak Syndrome 3

About this section

GO Terms for genes affiliated with Hermansky-Pudlak Syndrome 3

About this section

Cellular components related to Hermansky-Pudlak Syndrome 3 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1BLOC-2 complexGO:003108410.1HPS3, HPS5, HPS6
2melanosome membraneGO:00331629.2DCT, TYR, TYRP1
3melanosomeGO:00424708.8DCT, PMEL, TYR, TYRP1

Biological processes related to Hermansky-Pudlak Syndrome 3 according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1melanosome organizationGO:003243810.1PMEL, TYRP1
2organelle organizationGO:00069969.7HPS3, HPS5, HPS6
3melanin biosynthetic process from tyrosineGO:00065839.6DCT, TYR
4melanocyte differentiationGO:00303189.6HPS6, MITF, TYRP1
5developmental pigmentationGO:00480669.5DCT, PMEL
6melanin biosynthetic processGO:00424388.5DCT, PMEL, TYR, TYRP1
7pigmentationGO:00434738.2DCT, HPS3, HPS5, HPS6, TYR, TYRP1

Molecular functions related to Hermansky-Pudlak Syndrome 3 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1copper ion bindingGO:00055079.2DCT, TYR, TYRP1

Sources for Hermansky-Pudlak Syndrome 3

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet